What is your approach to management of severe osteoporosis in patients with advanced kidney disease?

Do you consider anabolic agents and if so, what is your approach to monitoring?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?

How do you approach decision-making around initiation of osteoporosis therapy in patients with advanced dementia?

What are the clinical prompts that lead you to consider deprescribing bisphosphonate therapy in older adults with osteoporosis?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.